Dimensional Fund Advisors
ENZ

Dimensional Fund Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Dimensional Fund Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-138,126
Closed -$51.5K – 3355
2025
Q1 		$51.5K Sell
138,126
-157,551
-53% -$87K ﹤0.01% 3258
2024
Q4 		$211K Sell
295,677
-8,815
-3% -$9.13K ﹤0.01% 3160
2024
Q3 		$341K Sell
304,492
-35,841
-11% -$40.1K ﹤0.01% 3094
2024
Q2 		$371K Sell
340,333
-315,462
-48% -$355K ﹤0.01% 3075
2024
Q1 		$833K Sell
655,795
-73,887
-10% -$97.6K ﹤0.01% 2951
2023
Q4 		$1.01M Sell
729,682
-113,404
-13% -$150K ﹤0.01% 2934
2023
Q3 		$1.18M Sell
843,086
-423,989
-33% -$639K ﹤0.01% 2883
2023
Q2 		$2.33M Sell
1,267,075
-254,608
-17% -$589K ﹤0.01% 2736
2023
Q1 		$3.7M Sell
1,521,683
-92,767
-6% -$138K ﹤0.01% 2576
2022
Q4 		$2.31K Buy
1,614,450
+20,585
+1% +$40.1K ﹤0.01% 2685
2022
Q3 		$3.55M Sell
1,593,865
-8,510
-0.5% -$20.6K ﹤0.01% 2536
2022
Q2 		$3.32M Buy
1,602,375
+7,834
+0.5% +$19.4K ﹤0.01% 2585
2022
Q1 		$4.62M Sell
1,594,541
-2,298
-0.1% -$7.38K ﹤0.01% 2559
2021
Q4 		$5.13M Buy
1,596,839
+42,690
+3% +$146K ﹤0.01% 2555
2021
Q3 		$5.5M Sell
1,554,149
-39,912
-3% -$133K ﹤0.01% 2553
2021
Q2 		$5.05M Sell
1,594,061
-39,162
-2% -$123K ﹤0.01% 2608
2021
Q1 		$5.62M Sell
1,633,223
-70,565
-4% -$219K ﹤0.01% 2538
2020
Q4 		$4.29M Sell
1,703,788
-219,578
-11% -$478K ﹤0.01% 2573
2020
Q3 		$4.06M Sell
1,923,366
-39,343
-2% -$93.5K ﹤0.01% 2512
2020
Q2 		$4.4M Sell
1,962,709
-103,656
-5% -$266K ﹤0.01% 2521
2020
Q1 		$5.23M Sell
2,066,365
-61,835
-3% -$152K ﹤0.01% 2386
2019
Q4 		$5.6M Sell
2,128,200
-14,785
-0.7% -$44.2K ﹤0.01% 2572
2019
Q3 		$7.71M Buy
2,142,985
+2,506
+0.1% +$8.87K ﹤0.01% 2453
2019
Q2 		$7.21M Buy
2,140,479
+36,031
+2% +$127K ﹤0.01% 2524
2019
Q1 		$5.75M Buy
2,104,448
+74,405
+4% +$244K ﹤0.01% 2604
2018
Q4 		$5.64M Sell
2,030,043
-12,558
-0.6% -$41.1K ﹤0.01% 2568
2018
Q3 		$8.41M Buy
2,042,601
+40,030
+2% +$182K ﹤0.01% 2504
2018
Q2 		$10.4M Sell
2,002,571
-17,079
-0.8% -$104K ﹤0.01% 2402
2018
Q1 		$11.1M Sell
2,019,650
-71,313
-3% -$502K ﹤0.01% 2338
2017
Q4 		$17M Sell
2,090,963
-57,054
-3% -$545K 0.01% 2141
2017
Q3 		$22.5M Buy
2,148,017
+121,370
+6% +$1.35M 0.01% 1981
2017
Q2 		$22.4M Buy
2,026,647
+193,246
+11% +$1.8M 0.01% 1954
2017
Q1 		$15.3M Sell
1,833,401
-53,131
-3% -$374K 0.01% 2124
2016
Q4 		$13.1M Sell
1,886,532
-6,310
-0.3% -$40.3K 0.01% 2194
2016
Q3 		$9.63M Buy
1,892,842
+78,912
+4% +$471K 0.01% 2267
2016
Q2 		$10.8M Buy
1,813,930
+133,285
+8% +$740K 0.01% 2199
2016
Q1 		$7.65M Buy
1,680,645
+151,276
+10% +$673K ﹤0.01% 2318
2015
Q4 		$6.88M Sell
1,529,369
-25,727
-2% -$109K ﹤0.01% 2385
2015
Q3 		$4.93M Sell
1,555,096
-164,535
-10% -$499K ﹤0.01% 2525
2015
Q2 		$5.21M Sell
1,719,631
-82,449
-5% -$232K ﹤0.01% 2569
2015
Q1 		$5.32M Sell
1,802,080
-85,974
-5% -$281K ﹤0.01% 2529
2014
Q4 		$8.38M Sell
1,888,054
-42,710
-2% -$204K 0.01% 2344
2014
Q3 		$9.94M Sell
1,930,764
-8,434
-0.4% -$45K 0.01% 2205
2014
Q2 		$10.2M Sell
1,939,198
-19,943
-1% -$86.2K 0.01% 2211
2014
Q1 		$8.15M Sell
1,959,141
-10,544
-0.5% -$36.1K 0.01% 2313
2013
Q4 		$5.75M Sell
1,969,685
-931
-0% -$2.31K ﹤0.01% 2496
2013
Q3 		$4.97M Sell
1,970,616
-10,837
-0.5% -$25.7K ﹤0.01% 2549
2013
Q2 		$4.12M Buy
+1,981,453
New +$4.37M ﹤0.01% 2569

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Dimensional Fund Advisors's ENZ Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 138,126 shares — an estimated $51.5K sold.

Dimensional Fund Advisors first reported a position in ENZ in Q2 2013 and held it in 48 quarters. The position peaked at $22.5M in Q3 2017. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 138,126 Enzo Biochem, Inc. shares in Q2 2025, an estimated $51.5K.
  • Dimensional Fund Advisors first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 48 quarters.
  • Dimensional Fund Advisors's Enzo Biochem, Inc. position peaked at $22.5M in Q3 2017.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.